Press Releases


Eppendorf and Bio-ITech demonstrate integrated digital lab workflows with the ELN eLabJournal for the first time at analytica 2016

Hamburg, May 2016

At the analytica, Eppendorf AG, in co-operation with the Dutch Life Science IT company Bio-ITech BV, will demonstrate the application-oriented use of an ELN (Electronic Lab Notebook), which is capable of significantly streamlining the planning and documentation of experiments as well as resource planning in the laboratory.

Successful series of experiments in research absolutely rely on complete and clear data capture. Many files are already generated in a digital format; therefore the mix of conventional paper-based records and digital analyses stands in the way of clear and complete documentation.The digital lab notebook by the company Bio-ITech offers consistent, secure, compliant and user-friendly documentation while taking relevant instrument data into consideration. This combination is key to efficient experiment and resource planning as well as to well-structured, long-term documentation.

At the Eppendorf booth at analytica, a typical application will be demonstrated for the inclusion of SOPs and instruments as well as experimental design and documentation. Different users may be associated with different rights. As an example, the sign-off process for experiments or the generation of new SOPs may be regulated in this manner.

The status of an experiment setup is always evident and thus allows efficient structuring of the daily laboratory routine with optimal utilization of resources. Finally, multiple experiments can be run simultaneously or used for a common analytical approach.
Hall B1, Booth 301


The new Eppendorf Tubes® 5.0 mL with screw cap

Eppendorf 5 mL screw cap

Hamburg, May 2016

The introduction of this new screw cap container represents the latest significant innovation within the Eppendorf Tubes® 5.0 mL system.

This tube will complement the application spectrum of sample processing in the medium volume range: in addition to sample processing the 5.0 mL screw cap tube is ideally suited for secure transport, long term storage at temperatures as low as -86 °C as well as sample incubation at up to 100 °C. In addition to a secure seal, the grooved and multi-surface side contours of the newly designed screw cap ensure a slip-free grip.

To accommodate the demands of individual laboratory protocols, the Eppendorf Tubes® 5.0 mL with screw cap are available in the certified purity grades “Eppendorf Quality”, “PCR clean” and “Sterile”.

Visit us at the analytica 2016, Hall B1, Booth 301


Eppendorf continues successful development

>        Group sales of €629.1 million (18.5% growth in sales)

>        Income from operations of €119.3 million (19.0% EBIT margin)

Hamburg, Germany, April 28, 2016 – The Eppendorf Group concluded fiscal year 2015 with Group sales of €629.1 million (prior year: €531.1 million) and growth in sales of 18.5% (7.1% when adjusted for currency effects). Income from operations (EBIT) climbed 24.7% to €119.3 million (prior year: €95.7 million).

Eppendorf’s growth last year encompassed all its product groups, and the company profited from the positive development of both traditional and new markets. Investments were made in the subsidiaries, including new facilities in Brazil and India, and in the expansion of Eppendorf’s sales structures. 2015 also saw an increase in research and development expenditures to €31.9 million (prior year: €29.4 million).

Thomas Bachmann, Chief Executive Officer of Eppendorf AG, was satisfied with the company’s result: “In 2015 we grew organically at a level well above the industry average of 4 to 5%, which is itself healthy. Significant success factors in our development are our innovative momentum, the high quality of our products, and a staff committed to doing the best for our customers every day. Our investments in sales and in the expansion of our services are also paying off.”

In 2016, the company intends to focus on device and data networking as well as product and application developments. Additional investments in the expansion of the country organizations and the development and production facilities are also planned.

The Eppendorf Annual Report 2015 is available on:  


Eppendorf – Your Expert and Adviser around Labs at the analytica 2016

Hamburg, April 2016

Under the motto “Next Generation of  Lab Solutions” Eppendorf presents on 223m² its newest product highlights in Munich: the refrigerated Centrifuge 5920 R with a capacity of four liters, the universal bioprocess control station BioFlo® 320, the brand-new Eppendorf Tubes® 5.0mL with screw caps as well as the dispenser generation E:  the Multipette® E3/E3x.

Apart from getting to know the newest product highlights, customers have the opportunity at to engage in a personal and application-oriented dialog about their process requirements and daily lab routine at the Eppendorf booth. To this end, Eppendorf has installed two transparent laboratories and offers guided tours twice a day. On these guided tours, application specialists explain the typical applications and processes in cell biology/NGS labs. Customers can discuss their daily tasks directly on site. In personal meetings with specialists they are afforded the opportunity to explore approaches to achieve reliable results. This may require an optimization of the entire lab process or simply small modifications of the daily lab routine. Useful tips are given that help to prevent contamination of cell cultures and to achieve homogenous and reproducible cell growth. In addition, customers will be presented intelligent solutions making daily lab routine less complex.

Demonstration of an ELN (Electronic Lab Notebook) in cooperation with the company Bio-ITech is also part of the presentation at the Eppendorf booth.

Furthermore, for the very first time Eppendorf offers free seminars on different topics in parallel to the fair. At these seminars (duration: approx. 1 hour per seminar) customers learn more about practice-oriented issues and enhance their knowledge, thereby reaping additional benefit from their visit to the fair. A certificate of attendance is awarded on demand.

For registration and time schedule of the guided tours see:

Hall B1, Booth 301


EU Funds Stem Cell Technologies for Heart Repair – Eppendorf is Project Partner

Cystic cardiac speroids of up to 1 mm size rhythmically contracting while floating in suspension culture. The speroids were generated from human pluripotent stem cells differentiated in stirred-tank bioreactors. Green fluorescence indicates cell differentiation into cardiomyocytes (Kempf et al., 2014, 2015).

Juelich, April 05th, 2016 – Within the EU Research and Innovation program Horizon 2020 the European Union is now funding the TECHNOBEAT research project with almost 6 million Euro. The pioneering project “Tools and TECHNOlogies for Breaktrough in hEArt Therapies” is coordinated by the Hannover Medical School. It will be processed by a pan-European and interdisciplinary consortium of eight partners from industry and science, one of them being Eppendorf. The scientists, medical experts, and engineers will cooperatively develop effective tools and innovative methods aiming for the production of cardiac microtissue for regenerative medicine. Primary cell material will be human induced pluripotent stem cells, so called hiPSCs.

Eppendorf is an industry-leading supplier of bioreactors and fermentors for the global biotech, pharmaceutical, and chemical industry as well as academia and research institutions. In the context of this EU project, DASGIP GmbH, an Eppendorf company, and the Eppendorf AG Bioprocess Center (both situated in Juelich, Germany), will develop innovative bioreactor solutions designed especially for the cultivation of hiPSCs in large scales. “We are pleased to have the Eppendorf Bioprocess Center in the TECHNOBEAT project team. In a long-standing cooperation we already have successfully developed bioreactors for the cultivation of 100 mL hiPSCs”, states Dr. Robert Zweigerdt, Principal Investigator at Hannover Medical School, Germany and TECHNOBEAT coordinator. “Now, the exciting challenge is to adapt the existing product design to the needs of stem cell cultivation in a larger volume of 1 L”, annotates Katharina Kinast, responsible Product Manager Bioprocess at Eppendorf. Development engineers and product managers at Eppendorf will create novel impeller and vessel designs to optimize hiPSCs culture mixing and shear characteristics. System-integrated filtering technology will be engineered. Holographic microscopy (industry partner Ovizio Imaging Systems NV/SA, Belgium) will be integrated as well. According to Katharina Kinast this will “altogether enable tight control and real-time monitoring of cell aggregate formation”. With its experience in polymer production and bioreactor design, Eppendorf will further contribute to establishing a GMP-conform hiPSC production process using single-use bioreactor technology.     

TECHNOBEAT can provide groundbreaking findings and methods that may revolutionize cell-based heart therapies. „In the future, the microtissues may be grown outside the body in bioreactors and then injected into the patients damaged heart as a cell implant for curative treatment“, outlines Robert Zweigerdt. “Hundreds of patients with cardiac diseases waiting for an organ transplant may benefit from this technology.”

The pan-European TECHNOBEAT project builds an integrated and application-oriented research approach. For the first time, the consortium combines technologies enabling the mass production of stem cells under defined quality criteria, a strategy for growth of implantable microtissue, methods for evaluation of implant success in mammals as well as designated clinical expertise in cardiology, cardiac surgery, and multimodal imaging.

By the cross-border networking of specialists and know-how, TECHNOBEAT supports the expansion and competiveness of the biomedical sector in Europe.

The project is funded for a period of four years. Apart from the Hannover Medical School and Eppendorf the following Institutions and companies are partnering the project: the Medical Centers at the universities of Leiden and Utrecht, the Netherlands, the University of Sheffield, UK, the Paracelsus Medical University, Austria and the industrial partners Ovizio Imaging Systems NV/SA, Belgium and Kadimastem Ltd., Israel.


Eppendorf named ‘Company of the Year’ by SelectScience® Reviewers

Kerry Parker, Editor in Chief SelectScience and Matin Khajooei, President & CEO Eppendorf North America

Hamburg, March 2016 - Eppendorf has been awarded the Company of the Year accolade in the SelectScience® Reviewers’ Choice Awards™ 2016, in recognition of the company’s contribution to scientific research over the past year. The leading life science company is amongst the winners who were officially announced during a ceremony held at Pittcon 2016 in Atlanta, Georgia. The Reviewers’ Choice Awards™, added to the annual Scientists’ Choice Awards® in 2015, give laboratory scientists an opportunity to have their say by rating and reviewing companies and products that have made a significant difference to their research over the past 12 months. The Company of the Year award acknowledges the business that achieves the highest weighted average across its product range on the SelectScience® site.

Eppendorf develops and sells instruments, consumables and services for liquid handling, sample handling, and cell handling in laboratories worldwide. The company has over 200 products showcased on SelectScience®, from pipettes and plates, to centrifuges and thermal cyclers, which have received almost 400 independent reviews from customers and scientists all over the world.

"Receiving this award means a great deal to us at Eppendorf.” said Matin Khajooei, President & CEO of Eppendorf North America. “We are particularly delighted to be recognized by our customers, SelectScience’s® reviewers, as everything we do here at Eppendorf is with our customers’ best interests in mind.” For more information about Eppendorf products, visit or to view the product range on SelectScience, visit


Eppendorf India Opens New Facility in Chennai

Chennai, March 2, 2016:  Eppendorf India Limited, a wholly-owned subsidiary of Eppendorf AG, today announces the setting up new facility at Ambattur, near Chennai.  Manned by a compact, elite team of scientists and engineers, this new facility will work on the skill development of Indian scientific fraternity by conducting world class training programs. The customer experience centre will showcase innovative technologies to new and existing customers.

Highlights of the new 46,000 square feet facility include:

>         Pipette calibration facility accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL)

>         NABL certified workshop for calibration services for temperature, speed and time

>         State-of-the-art laboratory and training facility

>         10,000 square feet of warehouse and a private bond store to deliver products even quicker to our customers

Thomas Bachmann, Chairman & CEO of the Eppendorf Group: “One of the cornerstones of our business strategy is to strengthen our global market position through targeted investments in both our sales structure and expansion of our training and service portfolio. Entering new product categories such as the Eppendorf Cell Culture Consumables are opening up new application areas and access to new customer groups. The new facility in India will be an important factor in these new product initiatives.”

Vancheeswaran Sankaranarayanan, Managing Director & CEO, Eppendorf India states: “During the decade-long presence of Eppendorf in India, we have extended significant support to the life sciences and biotechnology industry in India. Our dominant market position in India demonstrates the superiority of our products and underscores the importance of our training and service workshops extended to the clients’ R&D scientists continuously. With continually increasing demand for our premium products and services in India, Eppendorf India will work to increase considerably our customer-focussed initiatives with our new Customer Experience & Training Centre”.


Eppendorf & Science Prize for Neurobiology 2016. Call for Entries!

Hamburg, January 2016 - Eppendorf and the journal Science are now accepting applications for the 2016 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiology research based on methods of molecular and cell biology. Researchers who are not older than 35 years are invited to apply by June 15, 2016. The winner and finalists are selected by a committee of independent scientists, chaired by Science’s Senior Editor, Dr. Peter Stern.

The 2015 prize was won by the Japanese scientist Shigeki Watanabe, Ph.D., from Johns Hopkins University (Baltimore, USA). Shigeki Watanabe has developed two novel techniques in electron microscopy that allow visualization of protein and membrane dynamics at synapses at a millisecond temporal resolution. Using these techniques, he discovered an ultrafast mechanism that removes synaptic vesicle components rapidly from the plasma membrane following exocytosis. He further demonstrated that synaptic vesicles are regenerated from endosomes.

For more about the prize and film interview with Shigeki Watanabe, go to


Research on Synaptic Vesicle Endocytosis Wins 2015 Eppendorf & Science Prize

2015 winner: Shigeki Watanabe

Hamburg, October 2015 - The Japanese scientist Shigeki Watanabe, Ph.D., Postdoctoral Fellow at the University of Utah and Charité - Universitätsmedizin in Berlin has won the 2015 Eppendorf & Science Prize for Neurobiology for his work on vesicle endocytosis. Dr. Watanabe has developed two novel techniques in electron microscopy that allow visualization of protein and membrane dynamics at synapses at a millisecond temporal resolution.

Shigeki Watanabe writes, “Speed is a critical factor at synapses. To sustain synaptic transmission, synaptic vesicles must be reconstituted rapidly at synapses. To elucidate the mechanisms underlying synaptic vesicle recycling, I was able to combine optogenetic stimulation of neurons with high-pressure freezing and captured dynamic membrane movements in electron micrographs with a millisecond temporal resolution. The use of this technique has led to the discovery that a novel form of clathrin-independent endocytosis, now termed ‘ultrafast endocytosis’, retrieves vesicles from the plasma membrane immediately after vesicle fusion. I was further able to demonstrate that endocytic vesicles are delivered to a synaptic endosome, from which clathrin regenerates synaptic vesicles. These results indicate that the immediate role for endocytosis is perhaps not to recover synaptic vesicles, but rather to clear the fusion site so that another vesicle can fuse in rapid succession. The discovery of this recycling pathway will advance our understanding of the cellular and molecular underpinnings of the vesicle cycle at synapses.”

Dr. Watanabe is starting his own lab at Johns Hopkins University where his research will focus on understanding the mechanisms underlying the rapid reorganization of membrane, proteins, and organelles that mediate synaptic plasticity.

The annual US$25,000 Eppendorf & Science Prize for Neurobiology honors scientists, like Dr. Watanabe, for their outstanding contributions to neurobiology research. Shigeki Watanabe is the 14th recipient of this international award. The Prize is presented at a ceremony held in conjunction with the Annual Meeting of the Society for Neuroscience. All scientists who are 35 years of age or younger and who have made outstanding
contributions to neurobiological research based on methods of molecularand cell biology are invited to apply. The next deadline for applications for the Eppendorf & Science Prize for Neurobiology is June 15, 2016.

For more information about Dr. Watanabe and the Prize, visit


Call for entries: Eppendorf Award 2016!

Hamburg, October 2015 - From October 1, 2015, until January 15, 2016, young researchers working in Europe who are not older than 35 years can apply for the Eppendorf Award for Young European Investigators. This highly prestigious 20,000 EUR prize acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.

The winner is selected by an independent expert committee chaired by Reinhard Jahn (Max Planck Institute for Biophysical Chemistry, Göttingen, Germany).

The Award winner 2016 will receive

  • a prize money of 20,000 EUR
  • an invitation to the prize ceremony at the EMBL Advanced Training Centre in Heidelberg, Germany, on June 2, 2016
  • an invitation to visit Eppendorf AG in Hamburg, Germany
  • coverage of his/her work by Nature in print and online (including a podcast)

Full details on the Eppendorf Award, the selection criteria and Award winners since 1995 can be found at

Only online applications are accepted. The official online registration portal will accept applications as of October 1, 2015 at

The Eppendorf award for Young European Investigators is presented in partnership with Nature.

this website uses cookies. By using our website, you agree to the use of cookies.

More informationGot it!